BRANDES INVESTMENT PARTNERS, LP
Institutional investor · Portfolio as of Q1 2019
Top Holdings137 positions
EMBRAER S.A. | 19.9M | $382.8M | 8.9% | $18.92 | 0.00% | 1 qtr | First report 0 |
Cemex SAB de CV | 62.1M | $288.6M | 6.7% | $4.41 | 0.00% | 1 qtr | First report 0 |
NXP Semiconductors NV | 1.7M | $149.5M | 3.5% | $79.22 | 0.00% | 1 qtr | First report 0 |
Citigroup Inc | 2.1M | $128M | 3.0% | $48.26 | 0.00% | 1 qtr | First report 0 |
YPF SOCIEDAD ANONIMA | 8.6M | $121.2M | 2.8% | $13.90 | 0.00% | 1 qtr | First report 0 |
Merck & Co Inc | 1.4M | $115.8M | 2.7% | $63.02 | 0.00% | 1 qtr | First report 0 |
Pfizer Inc | 2.6M | $112.4M | 2.6% | $28.06 | 0.00% | 1 qtr | First report 0 |
SANOFI SPON ADR | 2.3M | $103.1M | 2.4% | $31.87 | 0.00% | 1 qtr | First report 0 |
FLEX LTD | 9.5M | $95.3M | 2.2% | $7.54 | 0.00% | 1 qtr | First report 0 |
Cardinal Health Inc | 1.9M | $92.8M | 2.2% | $39.65 | 0.00% | 1 qtr | First report 0 |
Wells Fargo & Co | 1.9M | $92.3M | 2.1% | $39.51 | 0.00% | 1 qtr | First report 0 |
Bank of America Corp | 3.3M | $91.7M | 2.1% | $23.03 | 0.00% | 1 qtr | First report 0 |
McKesson Corp | 770,837 | $90.2M | 2.1% | $111.11 | 0.00% | 1 qtr | First report 0 |
Bank of New York Mellon Corp/T | 1.7M | $87.4M | 2.0% | $40.96 | 0.00% | 1 qtr | First report 0 |
| 2.1M | $87.1M | 2.0% | — | — | 1 qtr | First report 0 | |
| 5.8M | $70M | 1.6% | — | — | 1 qtr | First report 0 | |
Emerson Electric Co | 1M | $70M | 1.6% | $57.87 | 0.00% | 1 qtr | First report 0 |
American International Group I | 1.5M | $66.7M | 1.6% | $36.19 | 0.00% | 1 qtr | First report 0 |
State Street Corp | 991,533 | $65.3M | 1.5% | $52.07 | 0.00% | 1 qtr | First report 0 |
GRUPO AVAL ACCIONES Y VALORE | 8.2M | $63.7M | 1.5% | $5.17 | 0.00% | 1 qtr | First report 0 |
BRANDES INVESTMENT PARTNERS, LP manages $4.3B across 137 positions as of Q1 2019. Top holdings: EMBJ (8.9%), CX (6.7%), NXPI (3.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2/5.0.
First quarter we have for this fund: 137 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $4.3B across 137 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR